期刊档案

Statistics in Biopharmaceutical Research

— · ISSN 1946-6315 · MATHEMATICAL & COMPUTATIONAL BIOLOGY-STATISTICS & PROBABILITY

数据可追溯 · letpub-v6 · 更新于 2026-08-26
影响指标1.54
h-index11
平均审稿速度期刊官网数据:平均Submission to first decision: 65 days; Submission to first post-review decision: 101 days; Acceptance to online publication: 48 days;网友分享经验:>12周,或约稿
平均录用比例网友分享经验:41%

期刊简介

研究范围与定位

Statistics in Biopharmaceutical Research ( SBR), publishes articles that focus on the needs of researchers and applied statisticians in biopharmaceutical industries; academic biostatisticians from schools of medicine, veterinary medicine, public health, and pharmacy; statisticians and quantitative analysts working in regulatory agencies (e.g., U.S. Food and Drug Administration and its counterpart in other countries); statisticians with an interest in adopting methodology presented in this journal to their own fields; and nonstatisticians with an interest in applying statistical methods to biopharmaceutical problems.Statistics in Biopharmaceutical Research accepts papers that discuss appropriate statistical methodology and information regarding the use of statistics in all phases of research, development, and practice in the pharmaceutical, biopharmaceutical, device, and diagnostics industries. Articles should focus on the development of novel statistical methods, novel applications of current methods, or the innovative application of statistical principles that can be used by statistical practitioners in these disciplines. Areas of application may include statistical methods for drug discovery, including papers that address issues of multiplicity, sequential trials, adaptive designs, etc.; preclinical and clinical studies; genomics and proteomics; bioassay; biomarkers and surrogate markers; models and analyses of drug history, including pharmacoeconomics, product life cycle, detection of adverse events in clinical studies, and postmarketing risk assessment; regulatory guidelines, including issues of standardization of terminology (e.g., CDISC), tolerance and specification limits related to pharmaceutical practice, and novel methods of drug approval; and detection of adverse events in clinical and toxicological studies. Tutorial articles also are welcome. Articles should include demonstrable evidence of the usefulness of this methodology (presumably by means of an application).The Editorial Board of SBR intends to ensure that the journal continually provides important, useful, and timely information. To accomplish this, the board strives to attract outstanding articles by seeing that each submission receives a careful, thorough, and prompt review.Authors can choose to publish gold open access in this journal.

结构化分区

学科分区明细

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值。

《新锐期刊分区表》( 2026年3月发布)

2026-03 · 3 个学科记录

Top:否综述:N/A
类别学科分区
大类医学4区
小类数学与计算生物学MATHEMATICAL & COMPUTATIONAL BIOLOGY4区
小类统计学与概率论STATISTICS & PROBABILITY4区

期刊分区表( 2025年3月升级版)

2025-03 · 3 个学科记录

Top:否综述:否
类别学科分区
大类医学4区
小类数学与计算生物学MATHEMATICAL & COMPUTATIONAL BIOLOGY3区
小类统计学与概率论STATISTICS & PROBABILITY4区

期刊分区表( 2023年12月旧的升级版)

2023-12 · 3 个学科记录

Top:否综述:否
类别学科分区
大类医学4区
小类数学与计算生物学MATHEMATICAL & COMPUTATIONAL BIOLOGY3区
小类统计学与概率论STATISTICS & PROBABILITY4区

期刊档案

出版与身份

期刊ISSN
1946-6315
是否OA开放访问
Yes (Hybrid,可自选是否OA)
通讯方式
TAYLOR & FRANCIS INC, 530 WALNUT STREET, STE 850, PHILADELPHIA, USA, PA, 19106
出版商
Taylor and Francis Ltd.
出版国家或地区
UNITED STATES
出版语言
English
出版周期
Quarterly
出版年份
2009

期刊档案

研究范围

期刊简介
Statistics in Biopharmaceutical Research ( SBR), publishes articles that focus on the needs of researchers and applied statisticians in biopharmaceutical industries; academic biostatisticians from schools of medicine, veterinary medicine, public health, and pharmacy; statisticians and quantitative analysts working in regulatory agencies (e.g., U.S. Food and Drug Administration and its counterpart in other countries); statisticians with an interest in adopting methodology presented in this journal to their own fields; and nonstatisticians with an interest in applying statistical methods to biopharmaceutical problems.Statistics in Biopharmaceutical Research accepts papers that discuss appropriate statistical methodology and information regarding the use of statistics in all phases of research, development, and practice in the pharmaceutical, biopharmaceutical, device, and diagnostics industries. Articles should focus on the development of novel statistical methods, novel applications of current methods, or the innovative application of statistical principles that can be used by statistical practitioners in these disciplines. Areas of application may include statistical methods for drug discovery, including papers that address issues of multiplicity, sequential trials, adaptive designs, etc.; preclinical and clinical studies; genomics and proteomics; bioassay; biomarkers and surrogate markers; models and analyses of drug history, including pharmacoeconomics, product life cycle, detection of adverse events in clinical studies, and postmarketing risk assessment; regulatory guidelines, including issues of standardization of terminology (e.g., CDISC), tolerance and specification limits related to pharmaceutical practice, and novel methods of drug approval; and detection of adverse events in clinical and toxicological studies. Tutorial articles also are welcome. Articles should include demonstrable evidence of the usefulness of this methodology (presumably by means of an application).The Editorial Board of SBR intends to ensure that the journal continually provides important, useful, and timely information. To accomplish this, the board strives to attract outstanding articles by seeing that each submission receives a careful, thorough, and prompt review.Authors can choose to publish gold open access in this journal.
涉及的研究方向
MATHEMATICAL & COMPUTATIONAL BIOLOGY-STATISTICS & PROBABILITY

期刊档案

指标与活跃度

2025-2026最新IF(数据来源于网友提供)
注册或登录后,查看IF
实时影响因子
截止2026年5月06日:1.54
2025-2026自引率
25.0%点击查看自引率趋势图
五年IF(数据来源于网友提供)
1.596数据由网友[喜欢大海nomad]收集提供
h-index
11
CiteScore ( 2026年6月最新版)
CiteScoreSJRSNIPCiteScore排名3.200.8740.973学科分区排名百分位大类:Mathematics小类:Statistics and ProbabilityQ298 / 303 67% 大类:Mathematics小类:Pharmaceutical ScienceQ292 / 191 52%
年文章数
59点击查看年文章数趋势图
Gold OA文章占比
9.76%
研究类文章占比:文章 ÷(文章 + 综述)
100.00%

期刊档案

分区、收录与风险

WOS期刊JCR分区 ( 2025-2026年最新版)
注册或登录后,查看WOS分区等级
期刊分区表预警名单
2026年03月发布的新锐学术版:不在预警名单中2025年03月发布的2025版:不在预警名单中2024年02月发布的2024版:不在预警名单中2023年01月发布的2023版:不在预警名单中2021年12月发布的2021版:不在预警名单中2020年12月发布的2020版:不在预警名单中
SCI期刊收录coverage
Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)Scopus (CiteScore)
PubMed Central (PMC)链接
访问官方页面 ↗

期刊档案

投稿与评审

期刊官方网站
访问官方页面 ↗
期刊投稿网址
访问官方页面 ↗
作者指南网址
访问官方页面 ↗
平均审稿速度
期刊官网数据:平均Submission to first decision: 65 days; Submission to first post-review decision: 101 days; Acceptance to online publication: 48 days;网友分享经验:>12周,或约稿
平均录用比例
网友分享经验:41%

来源与统计口径

来源:LetPub 原始详情页 ↗。投稿经验仅展示聚合统计,不公开第三方正文或用户标识。当前聚合样本:暂无。